London · Delayed Price · Currency is GBP · Price in GBX GSK plc Statistics
Total Valuation
GSK plc has a market cap or net worth of GBP 85.92 billion. The enterprise value is 99.81 billion.
| Market Cap | 85.92B |
| Enterprise Value | 99.81B |
Important Dates
The last earnings date was Wednesday, February 4, 2026.
| Earnings Date | Feb 4, 2026 |
| Ex-Dividend Date | Feb 19, 2026 |
Share Statistics
GSK plc has 4.01 billion shares outstanding. The number of shares has decreased by -0.60% in one year.
| Current Share Class | 4.01B |
| Shares Outstanding | 4.01B |
| Shares Change (YoY) | -0.60% |
| Shares Change (QoQ) | -0.39% |
| Owned by Insiders (%) | 0.05% |
| Owned by Institutions (%) | 86.43% |
| Float | 3.87B |
Valuation Ratios
The trailing PE ratio is 15.43 and the forward PE ratio is 11.76. GSK plc's PEG ratio is 2.03.
| PE Ratio | 15.43 |
| Forward PE | 11.76 |
| PS Ratio | 2.63 |
| PB Ratio | 5.38 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 13.44 |
| P/OCF Ratio | 11.10 |
| PEG Ratio | 2.03 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.56, with an EV/FCF ratio of 15.61.
| EV / Earnings | 17.46 |
| EV / Sales | 3.06 |
| EV / EBITDA | 7.56 |
| EV / EBIT | 10.58 |
| EV / FCF | 15.61 |
Financial Position
The company has a current ratio of 0.82, with a Debt / Equity ratio of 1.11.
| Current Ratio | 0.82 |
| Quick Ratio | 0.52 |
| Debt / Equity | 1.11 |
| Debt / EBITDA | 1.34 |
| Debt / FCF | 2.77 |
| Interest Coverage | 13.46 |
Financial Efficiency
Return on equity (ROE) is 43.31% and return on invested capital (ROIC) is 26.51%.
| Return on Equity (ROE) | 43.31% |
| Return on Assets (ROA) | 9.78% |
| Return on Invested Capital (ROIC) | 26.51% |
| Return on Capital Employed (ROCE) | 23.74% |
| Weighted Average Cost of Capital (WACC) | 5.34% |
| Revenue Per Employee | 475,994 |
| Profits Per Employee | 83,288 |
| Employee Count | 68,629 |
| Asset Turnover | 0.54 |
| Inventory Turnover | 1.54 |
Taxes
In the past 12 months, GSK plc has paid 1.11 billion in taxes.
| Income Tax | 1.11B |
| Effective Tax Rate | 15.02% |
Stock Price Statistics
The stock price has increased by +48.32% in the last 52 weeks. The beta is 0.27, so GSK plc's price volatility has been lower than the market average.
| Beta (5Y) | 0.27 |
| 52-Week Price Change | +48.32% |
| 50-Day Moving Average | 1,881.25 |
| 200-Day Moving Average | 1,611.64 |
| Relative Strength Index (RSI) | 71.63 |
| Average Volume (20 Days) | 9,447,308 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, GSK plc had revenue of GBP 32.67 billion and earned 5.72 billion in profits. Earnings per share was 1.39.
| Revenue | 32.67B |
| Gross Profit | 23.72B |
| Operating Income | 9.43B |
| Pretax Income | 7.40B |
| Net Income | 5.72B |
| EBITDA | 13.21B |
| EBIT | 9.43B |
| Earnings Per Share (EPS) | 1.39 |
Balance Sheet
The company has 3.41 billion in cash and 17.72 billion in debt, with a net cash position of -14.31 billion or -3.57 per share.
| Cash & Cash Equivalents | 3.41B |
| Total Debt | 17.72B |
| Net Cash | -14.31B |
| Net Cash Per Share | -3.57 |
| Equity (Book Value) | 15.96B |
| Book Value Per Share | 4.08 |
| Working Capital | -3.88B |
Cash Flow
In the last 12 months, operating cash flow was 7.74 billion and capital expenditures -1.35 billion, giving a free cash flow of 6.39 billion.
| Operating Cash Flow | 7.74B |
| Capital Expenditures | -1.35B |
| Free Cash Flow | 6.39B |
| FCF Per Share | 1.59 |
Margins
Gross margin is 72.61%, with operating and profit margins of 28.87% and 17.50%.
| Gross Margin | 72.61% |
| Operating Margin | 28.87% |
| Pretax Margin | 22.66% |
| Profit Margin | 17.50% |
| EBITDA Margin | 40.44% |
| EBIT Margin | 28.87% |
| FCF Margin | 19.57% |
Dividends & Yields
This stock pays an annual dividend of 0.72, which amounts to a dividend yield of 3.35%.
| Dividend Per Share | 0.72 |
| Dividend Yield | 3.35% |
| Dividend Growth (YoY) | 8.20% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 44.86% |
| Buyback Yield | 0.60% |
| Shareholder Yield | 3.95% |
| Earnings Yield | 6.65% |
| FCF Yield | 7.44% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 19, 2022. It was a reverse split with a ratio of 0.8.
| Last Split Date | Jul 19, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.8 |
Scores
GSK plc has an Altman Z-Score of 2.02 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.02 |
| Piotroski F-Score | 7 |